Skip to main content
. 2012 May 17;103(7):1334–1341. doi: 10.1111/j.1349-7006.2012.02306.x

Figure 1.

Figure 1

Kaplan–Meier estimates of the impact of molecular subclasses on (a,c) progression‐free survival for patients with (a) serous (P = 0.089) and (c) non‐serous (P < 0.001; log rank test) epithelial ovarian cancer (EOC) and (b,d) overall survival for patients with (b) serous (P = 0.001) and (d) non‐serous (P < 0.001; log rank test) EOC.